Adjusted Body Weight
Ideal and adjusted body weight for clinical dosing.
Adjusted body weight
184.6 lb
IBW 160.9 lb
Ideal body weight
160.9 lb
Actual weight
220 lb
AI Breakdown & Smart Takeaway
Plain-English insight on your numbers
Get a personalized explanation of what these results mean — and how to improve them.
How the Adjusted Body Weight works
The Adjusted Body Weight (ABW) calculator determines the clinically appropriate weight for drug dosing in obese patients, combining Ideal Body Weight (IBW) with a correction factor to account for the distribution of certain medications into excess adipose tissue. It is primarily used by pharmacists, physicians, nurses, and other clinicians to avoid both under-dosing and toxicity in patients whose actual weight significantly exceeds their ideal weight.
The foundation of this calculator is the Ideal Body Weight formula developed by Dr. B.J. Devine in 1974, originally intended to predict creatinine clearance rather than serve as a dosing benchmark. Devine's equations calculate IBW from height and sex: for males, IBW = 50 kg + 2.3 kg per inch over 5 feet; for females, IBW = 45.5 kg + 2.3 kg per inch over 5 feet. These figures represent the weight at which organ function and physiology are considered 'typical,' and they serve as the anchor point from which Adjusted Body Weight is derived.
Adjusted Body Weight is calculated as: ABW = IBW + 0.4 × (Actual Body Weight − IBW). The correction factor of 0.4 (40%) reflects the empirical observation that lean tissue and well-perfused adipose compartments in obese patients still contribute to drug distribution—but not to the same degree as in non-obese patients. Without this adjustment, dosing an obese patient on actual body weight alone can lead to dangerously high plasma concentrations for drugs with limited fat solubility, while dosing purely on IBW can result in therapeutic failure for drugs that do distribute into adipose tissue.
ABW is most commonly applied when a patient's actual body weight exceeds their IBW by more than 20–30%, a threshold that many clinical guidelines use to trigger the switch from IBW to ABW. Classic drug classes where ABW is preferred include aminoglycoside antibiotics (e.g., gentamicin, tobramycin), heparin infusions, and certain chemotherapy regimens. For drugs that are highly lipophilic—such as some benzodiazepines or propofol—Total Body Weight (TBW) may actually be more appropriate, so understanding the pharmacokinetic profile of the specific drug is always the critical first step before choosing which weight scalar to use.
A common clinical mistake is applying ABW universally to all obese patients without checking whether the actual body weight is already close to or below the calculated IBW. If a patient's actual weight is less than their IBW—which can occur in malnourished or pediatric patients—ABW loses its mathematical meaning and actual body weight or IBW should be used directly. Additionally, clinicians should always re-verify height measurements rather than relying on patient-reported height, since even a 1–2 inch error in height can meaningfully shift the IBW and therefore the ABW, affecting the calculated dose.
Formula
ABW = IBW + 0.4 × (actual − IBW); IBW by Devine formula
Pro tips
- Always measure the patient's height directly rather than using self-reported values—a 2-inch discrepancy can shift IBW by approximately 4.6 kg and meaningfully change the calculated dose.
- Check your institution's drug-specific guidelines before defaulting to ABW: aminoglycosides and heparin commonly use ABW, but some lipophilic drugs like propofol or certain antiretrovirals require Total Body Weight.
- If the patient's actual body weight is less than the calculated IBW, skip ABW entirely and dose on actual body weight—using ABW in this scenario produces a nonsensical result greater than the patient's real weight.
- For pediatric patients, the Devine-based ABW formula is not validated; use age- and population-specific dosing weight guidelines approved for pediatric pharmacokinetics.
- Document which weight scalar you used and why in clinical notes—auditors and pharmacists reviewing orders need to confirm the dosing rationale, especially for high-alert medications like aminoglycosides.
Key terms
- Ideal Body Weight (IBW)
- — A calculated weight based solely on height and sex using the Devine formula, representing the expected weight of a person of that stature independent of fat mass.
- Adjusted Body Weight (ABW)
- — A corrected weight scalar that adds 40% of the excess weight above IBW to account for partial drug distribution into adipose tissue in obese patients.
- Correction Factor (0.4)
- — The empirically derived constant in the ABW formula representing the proportion of excess adipose tissue that contributes to drug distribution volume.
- Total Body Weight (TBW)
- — The patient's actual measured weight, used for dosing highly lipophilic drugs or as a baseline input when calculating ABW.
- Obesity Threshold
- — The point—typically when actual body weight exceeds IBW by ≥20–30%—at which clinical guidelines recommend switching from IBW to ABW for drug dosing.
- Devine Formula
- — The 1974 equations by B.J. Devine that calculate sex-specific ideal body weight from height in inches, forming the basis of most clinical dosing weight calculations.